Australia's Telix starts US trial

Australia's Telix Pharmaceuticals has announced first commercial doses of its prostate cancer imaging agent, Illuccix&re...

April 18, 2022 | Monday | News
US authorises first COVID-19 diagnostic test using breath samples

U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the first COVID-19 diagnosti...

April 15, 2022 | Friday | News
China approves Fosun Diagnostics' COVID-19 antigen detection kit

Shanghai Fosun Pharmaceutical (Group) has announced that the novel coronavirus (2019-nCoV) antigen detection kit (Colloi...

April 15, 2022 | Friday | News
Hong Kong develops portable nucleic acid testing device for COVID-19

In 2020, an interdisciplinary research team from The Hong Kong Polytechnic University (PolyU) was awarded over HK$2.7 mi...

April 14, 2022 | Thursday | News
Artemis DNA announces international expansion to Vietnam

US-based Artemis DNA, Inc. will be opening the first international location in Ho Chi Minh City, Vietnam. ...

April 12, 2022 | Tuesday | News
Live Webinar: Staying Ahead of Viral Variants: Surveillance Solutions for SARS-CoV-2

Click here to register now   Event Details Date: Friday, 29 April 2022 Time: 10:00 AM (GMT+8; Singapore and Tai...

April 11, 2022 | Monday | News
SeekIn receives CE Mark approval for LeukoPrint molecular karyotyping test

SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, has announced the CE (Conformit&...

April 8, 2022 | Friday | News
Medriva announces availability of new COVID-19 Rapid Antigen Test kits in Australia

Medriva, a leading global manufacturer of COVID-19 testing and vaccination products, has announced the Australian a...

April 8, 2022 | Friday | News
Seegene's Allplex RV Master assay receives Australian TGA approval, European CE-IVD mark

Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, announced that its Allplex RV Master Assay has ...

April 7, 2022 | Thursday | News
Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix

Australia-based Telix Pharmaceuticals has signed an exclusive agreement with Xiel Limited (Xiel) for the distributi...

March 29, 2022 | Tuesday | News
Breakthrough urine liquid biopsy prostate cancer test launches in Singapore

miR Scientific, a New York-based healthcare company dedicated to transforming global cancer management, and&nb...

March 29, 2022 | Tuesday | News
Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary

Seegene Inc. , South Korea's leading molecular diagnostics company, announced the appointment of Dr. Glen Hans...

March 18, 2022 | Friday | News
DEKRA inks MoU with Korea Testing Laboratory

DEKRA has signed the Memorandum of Understanding (MoU) with Korea Testing Laboratory (KTL) to develop cooperation opport...

March 16, 2022 | Wednesday | News
Vietnam-based startup Gene Solutions makes early cancer detection possible

The scientific research team from Gene Solutions, a startup based in Vietnam, has invented a SPOT-MAS liquid biopsy...

March 16, 2022 | Wednesday | News
Japan approves Guardant Health's liquid biopsy test for tumour mutation profiling

The Ministry of Health, Labour and Welfare (MHLW) in Japan has granted regulatory approval of Guardant360 CDx, a liquid ...

March 14, 2022 | Monday | News
Everlife boosts presence in strategic life sciences and clinical diagnostics segments in South East Asia

Singapore-based Everlife Holdings, a leading market access and distribution company in India and South East Asia, h...

March 10, 2022 | Thursday | News
Pathomics Health expands lab operations to Singapore

Diagnostics and research service provider Pathomics Health has announced its laboratory operations expansion into Singap...

March 8, 2022 | Tuesday | News
Korea's GC Labs partners with firms in Middle East and Cambodia

GC Labs,  the leading clinical diagnostics company in Korea, has  announced the new lab testing service a...

March 3, 2022 | Thursday | News